However, the amplification of PAK2 (as well as PAK2-related genes) is considerably more common in cancer than is inactivation and missense mutations of Pak2 phosphorylation sites in Myc are virtually non-existent [143,144,150,151]. The gene discussed is MYC; the disease is cancer.